BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 309 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $12,181,000 | +20.6% | 83,600 | -1.9% | 0.04% | +29.6% |
| Q1 2022 | $10,102,000 | +53.4% | 85,200 | +78.2% | 0.03% | +68.8% |
| Q4 2021 | $6,587,000 | +21.9% | 47,800 | +22.9% | 0.02% | +14.3% |
| Q3 2021 | $5,404,000 | +223.6% | 38,900 | +59.2% | 0.01% | +180.0% |
| Q1 2021 | $1,670,000 | -74.7% | 24,430 | -68.3% | 0.01% | -72.2% |
| Q4 2020 | $6,611,000 | -27.5% | 77,130 | -45.0% | 0.02% | -30.8% |
| Q3 2020 | $9,116,000 | +6.9% | 140,230 | +20.2% | 0.03% | +4.0% |
| Q2 2020 | $8,527,000 | +49.0% | 116,630 | -30.6% | 0.02% | +13.6% |
| Q1 2020 | $5,721,000 | -65.5% | 168,130 | -44.7% | 0.02% | -42.1% |
| Q4 2019 | $16,562,000 | +52.1% | 304,230 | +16.5% | 0.04% | +40.7% |
| Q3 2019 | $10,890,000 | +30.2% | 261,030 | +36.7% | 0.03% | +28.6% |
| Q2 2019 | $8,361,000 | +59.8% | 190,930 | +87.9% | 0.02% | +61.5% |
| Q1 2019 | $5,231,000 | +741.0% | 101,630 | +503.9% | 0.01% | +550.0% |
| Q4 2018 | $622,000 | – | 16,830 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |